Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierluigi Viale

Showing results (61-70 of 466) with videos related to

Pageof 47
Sort By:
Antibiotics (Basel, Switzerland)|December 23, 2022
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant <i>Pseudomonas aeruginosa</i> Bloodstream Infections and/or Hospital-Acquired PneumoniaMilo Gatti, Maddalena Giannella, Matteo Rinaldi, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing <i>Enterobacterales</i> Bloodstream Infections and/or Ventilator-Associated Pneumonia?Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
Le Infezioni in Medicina|June 26, 2015
Salmonella paratyphi B mycotic aneurysm of the abdominal aorta in an HIV-infected patient: a case reportNicolò Girometti, Maddalena Giannella, Stefano Brocchi, et al.
Antibiotics (Basel, Switzerland)|April 26, 2024
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAPMilo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
HIV Medicine|April 3, 2024
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gainLeonardo Calza, Maddalena Giglia, Vincenzo Colangeli, et al.
Antibiotics (Basel, Switzerland)|November 24, 2023
Role of a Real-Time TDM-Based Expert Clinical Pharmacological Advice Program in Optimizing the Early Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Beta-Lactams among Orthotopic Liver Transplant Recipients with Documented or Suspected Gram-Negative InfectionsMilo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Antibiotics (Basel, Switzerland)|October 27, 2023
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous HemodiafiltrationMilo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2016
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patientsLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
Antibiotics (Basel, Switzerland)|March 27, 2026
Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction?Pier Giorgio Cojutti, Renato Pascale, Andrea Grechi, et al.
Antibiotics (Basel, Switzerland)|September 28, 2023
Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative InfectionsPasquale Maria Berrino, Milo Gatti, Matteo Rinaldi, et al.
Pageof 47

Showing results (61-70 of 466) with videos related to

Sort By:
Pageof 47
Antibiotics (Basel, Switzerland)|December 23, 2022
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant <i>Pseudomonas aeruginosa</i> Bloodstream Infections and/or Hospital-Acquired PneumoniaMilo Gatti, Maddalena Giannella, Matteo Rinaldi, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing <i>Enterobacterales</i> Bloodstream Infections and/or Ventilator-Associated Pneumonia?Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
Le Infezioni in Medicina|June 26, 2015
Salmonella paratyphi B mycotic aneurysm of the abdominal aorta in an HIV-infected patient: a case reportNicolò Girometti, Maddalena Giannella, Stefano Brocchi, et al.
Antibiotics (Basel, Switzerland)|April 26, 2024
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAPMilo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
HIV Medicine|April 3, 2024
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gainLeonardo Calza, Maddalena Giglia, Vincenzo Colangeli, et al.
Antibiotics (Basel, Switzerland)|November 24, 2023
Role of a Real-Time TDM-Based Expert Clinical Pharmacological Advice Program in Optimizing the Early Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Beta-Lactams among Orthotopic Liver Transplant Recipients with Documented or Suspected Gram-Negative InfectionsMilo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Antibiotics (Basel, Switzerland)|October 27, 2023
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous HemodiafiltrationMilo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2016
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patientsLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
Antibiotics (Basel, Switzerland)|March 27, 2026
Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction?Pier Giorgio Cojutti, Renato Pascale, Andrea Grechi, et al.
Antibiotics (Basel, Switzerland)|September 28, 2023
Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative InfectionsPasquale Maria Berrino, Milo Gatti, Matteo Rinaldi, et al.
Pageof 47